Similar articles

• Repeatability of tumour hypoxia imaging using [¹⁸F]EF5 PET/CT in head and neck cancer.

  Silvoniemi A, Suilamo S, Laitinen T, Forsback S, Löyttyniemi E, Vaittinen S, Saunavaara V, Solin O, Grönroos TJ, Minn H. Silvoniemi A, et al. Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):161-169. doi: 10.1007/s00259-017-3857-3. Epub 2017 Oct 26. Eur J Nucl Med Mol Imaging. 2018. PMID: 29075831 Free PMC article. Clinical Trial.
• Repeatability of hypoxia dose painting by numbers based on EF5-PET in head and neck cancer.

  Wright P, Arnesen MR, Lønne PI, Suilamo S, Silvoniemi A, Dale E, Minn H, Malinen E. Wright P, et al. Acta Oncol. 2021 Nov;60(11):1386-1391. doi: 10.1080/0284186X.2021.1944663. Epub 2021 Jun 29. Acta Oncol. 2021. PMID: 34184605
• Atypical ¹⁸F-FDG PET-CT uptake in the head and neck; a case-based pictorial review.

  Childs L, Thompson A, Jones H, Hameeduddin A, Ghufoor K, Adams A. Childs L, et al. Clin Imaging. 2018 May-Jun;49:136-143. doi: 10.1016/j.clinimag.2018.01.006. Epub 2018 Jan 10. Clin Imaging. 2018. PMID: 29414508 Review.
• ¹⁸F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy.

  Qian Y, Von Eyben R, Liu Y, Chin FT, Miao Z, Apte S, Carter JN, Binkley MS, Pollom EL, Harris JP, Prionas ND, Kissel M, Simmons A, Diehn M, Shultz DB, Brown JM, Maxim PG, Koong AC, Graves EE, Loo BW Jr. Qian Y, et al. Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1183-1192. doi: 10.1016/j.ijrobp.2018.03.045. Epub 2018 Apr 18. Int J Radiat Oncol Biol Phys. 2018. PMID: 29859786
• Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck.

  Zimmer LA, Branstetter BF, Nayak JV, Johnson JT. Zimmer LA, et al. Laryngoscope. 2005 Nov;115(11):2029-34. doi: 10.1097/01.MLG.0000181495.94611.A6. Laryngoscope. 2005. PMID: 16319618 Review.